Gilead Sciences reported $4.78B in Trade Debtors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acorda Therapeutics ACOR:US USD 13.87M 824K
Agios Pharmaceuticals AGIO:US USD 2.21M 3.39M
Alnylam Pharmaceuticals ALNY:US USD 237.96M 53.45M
Amgen AMGN:US USD 5.56B 237M
Biogen BIIB:US USD 2.14B 152.2M
Biomarin Pharmaceutical BMRN:US USD 461.32M 41.69M
Coherus Biosciences CHRS:US USD 109.96M 18.78M
Gilead Sciences GILD:US USD 4.78B 423M
GlaxoSmithKline GSK:LN GBP 7.46B 636M
Glaxosmithkline GSK:US GBP 7.46B 636M
Intercept Pharmaceuticals ICPT:US USD 26.86M 694K
Moderna Inc MRNA:US USD 1.63B 1.19B
Neurocrine Biosciences NBIX:US USD 350M 48.8M
Novartis NOVN:VX USD 8.33B 346M
Ptc Therapeutics PTCT:US USD 155.61M 31.16M
Puma Biotechnology PBYI:US USD 42.27M 10.39M
Regeneron Pharmaceuticals REGN:US USD 5.33B 219.6M
Sangamo Biosciences SGMO:US USD 4.47M 574K
Sarepta Therapeutics SRPT:US USD 259.7M 36.25M
Teva Pharmaceutical Industries TEVA:US USD 3.7B 34M
United Therapeutics UTHR:US USD 220.4M 11.3M
Vertex Pharmaceuticals VRTX:US USD 1.44B 57M
YTE INCY:US USD 644.88M 26.69M